MR can reveal and characterize unsuspected pelvic organ prolapse in women, according to a study presented at the 2006 Society of Computed Body Tomography and Magnetic Resonance meeting.
MR can reveal and characterize unsuspected pelvic organ prolapse in women, according to a study presented at the 2006 Society of Computed Body Tomography and Magnetic Resonance meeting.
Researchers at New York University, led by Dr. Genevieve L. Bennett, retrospectively reviewed MRI data from 99 women referred for several indications. Patients underwent dynamic TrueFisp scanning at 1.5T, alternating between rest and strain. Dynamic MRI confirmed pelvic organ prolapse in five patients at rest and also detected the condition in 33 patients during stress maneuvers. Researchers did not find a significant correlation between the original indication for imaging and the MR findings, however.
"We routinely use dynamic MRI in this patient population. The sequence requires less than a minute of additional imaging time," Bennett said.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.